| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss, Sensorineural | 34 | 2023 | 770 | 6.560 |
Why?
|
| Hearing Loss | 29 | 2022 | 765 | 5.280 |
Why?
|
| Vestibular Aqueduct | 11 | 2023 | 66 | 3.010 |
Why?
|
| Deafness | 18 | 2023 | 458 | 2.410 |
Why?
|
| Tonsillectomy | 16 | 2022 | 255 | 1.790 |
Why?
|
| Audiometry, Pure-Tone | 9 | 2023 | 204 | 1.780 |
Why?
|
| Connexins | 13 | 2023 | 357 | 1.700 |
Why?
|
| Otitis Media | 11 | 2018 | 277 | 1.690 |
Why?
|
| Usher Syndromes | 3 | 2021 | 50 | 1.630 |
Why?
|
| Cochlear Implantation | 12 | 2023 | 310 | 1.590 |
Why?
|
| Cochlear Implants | 12 | 2023 | 339 | 1.450 |
Why?
|
| Hearing Loss, Unilateral | 3 | 2022 | 26 | 1.270 |
Why?
|
| Adenoidectomy | 12 | 2022 | 159 | 1.220 |
Why?
|
| Ear, Middle | 10 | 2015 | 334 | 1.000 |
Why?
|
| Diagnostic Techniques, Otological | 1 | 2021 | 12 | 0.780 |
Why?
|
| Child | 100 | 2023 | 77709 | 0.770 |
Why?
|
| Temporal Bone | 7 | 2015 | 661 | 0.740 |
Why?
|
| Lymphadenitis | 5 | 2018 | 98 | 0.740 |
Why?
|
| Cytomegalovirus Infections | 3 | 2022 | 820 | 0.730 |
Why?
|
| Torticollis | 2 | 2020 | 66 | 0.710 |
Why?
|
| Sexual Harassment | 1 | 2020 | 79 | 0.700 |
Why?
|
| Child, Preschool | 78 | 2022 | 41006 | 0.690 |
Why?
|
| Ear, Inner | 3 | 2015 | 420 | 0.680 |
Why?
|
| Middle Ear Ventilation | 5 | 2018 | 94 | 0.640 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2018 | 19 | 0.640 |
Why?
|
| Infant | 58 | 2023 | 35136 | 0.620 |
Why?
|
| Otitis Media with Effusion | 8 | 2008 | 114 | 0.620 |
Why?
|
| Stomatitis, Aphthous | 4 | 2016 | 53 | 0.600 |
Why?
|
| Otolaryngology | 3 | 2022 | 645 | 0.600 |
Why?
|
| Blindness | 1 | 2021 | 617 | 0.580 |
Why?
|
| Vaccines, Conjugate | 1 | 2018 | 333 | 0.570 |
Why?
|
| Pharyngitis | 4 | 2016 | 215 | 0.550 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 2 | 2016 | 13 | 0.540 |
Why?
|
| Retropharyngeal Abscess | 1 | 2015 | 21 | 0.540 |
Why?
|
| Postoperative Hemorrhage | 3 | 2020 | 413 | 0.530 |
Why?
|
| Cochlear Nerve | 3 | 2012 | 197 | 0.530 |
Why?
|
| Vestibular Diseases | 3 | 2021 | 217 | 0.520 |
Why?
|
| Audiometry | 9 | 2016 | 241 | 0.520 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2021 | 1676 | 0.510 |
Why?
|
| Pharyngeal Diseases | 2 | 2015 | 133 | 0.500 |
Why?
|
| Pneumococcal Vaccines | 1 | 2018 | 391 | 0.490 |
Why?
|
| Workplace | 1 | 2020 | 836 | 0.480 |
Why?
|
| Physicians, Women | 1 | 2020 | 486 | 0.480 |
Why?
|
| Speech Perception | 4 | 2023 | 489 | 0.470 |
Why?
|
| Office Visits | 1 | 2018 | 598 | 0.470 |
Why?
|
| Genetic Testing | 9 | 2022 | 3444 | 0.460 |
Why?
|
| Deglutition Disorders | 2 | 2018 | 605 | 0.440 |
Why?
|
| Vestibular Function Tests | 5 | 2015 | 127 | 0.440 |
Why?
|
| Hearing Aids | 3 | 2021 | 55 | 0.440 |
Why?
|
| Hearing Loss, Sudden | 1 | 2013 | 43 | 0.430 |
Why?
|
| Membrane Transport Proteins | 6 | 2016 | 1028 | 0.430 |
Why?
|
| Neck | 3 | 2018 | 697 | 0.420 |
Why?
|
| Hearing Loss, Conductive | 4 | 2016 | 158 | 0.410 |
Why?
|
| Labyrinth Diseases | 3 | 2010 | 150 | 0.410 |
Why?
|
| Consensus | 1 | 2021 | 2959 | 0.400 |
Why?
|
| Alleles | 12 | 2021 | 6933 | 0.400 |
Why?
|
| Hearing | 5 | 2023 | 482 | 0.400 |
Why?
|
| Otitis Media, Suppurative | 6 | 1998 | 26 | 0.390 |
Why?
|
| Cytomegalovirus | 1 | 2015 | 732 | 0.380 |
Why?
|
| DNA Mutational Analysis | 8 | 2016 | 4186 | 0.380 |
Why?
|
| Adolescent | 53 | 2021 | 85781 | 0.370 |
Why?
|
| Hearing Loss, Bilateral | 3 | 2022 | 54 | 0.370 |
Why?
|
| Guideline Adherence | 1 | 2021 | 2266 | 0.370 |
Why?
|
| Adenoids | 2 | 2008 | 33 | 0.350 |
Why?
|
| Cystic Fibrosis | 3 | 2016 | 1177 | 0.350 |
Why?
|
| Humans | 149 | 2023 | 744343 | 0.340 |
Why?
|
| Genotype | 9 | 2021 | 12951 | 0.330 |
Why?
|
| Mutation | 25 | 2023 | 29786 | 0.330 |
Why?
|
| Retrospective Studies | 42 | 2023 | 77449 | 0.320 |
Why?
|
| Phosphorylcholine | 1 | 2008 | 162 | 0.310 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2007 | 1888 | 0.300 |
Why?
|
| Cochlea | 5 | 2020 | 828 | 0.300 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2708 | 0.290 |
Why?
|
| Infant, Newborn | 25 | 2023 | 25625 | 0.290 |
Why?
|
| Acute Disease | 4 | 2016 | 7149 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 16 | 2015 | 20129 | 0.280 |
Why?
|
| Male | 91 | 2023 | 350118 | 0.280 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2008 | 145 | 0.270 |
Why?
|
| Acetyltransferases | 3 | 2004 | 234 | 0.270 |
Why?
|
| Bacteriophages | 2 | 2020 | 356 | 0.270 |
Why?
|
| Female | 85 | 2023 | 380194 | 0.270 |
Why?
|
| Cost of Illness | 1 | 2015 | 1859 | 0.270 |
Why?
|
| Saccharomyces cerevisiae | 11 | 2006 | 2752 | 0.260 |
Why?
|
| Myosins | 2 | 2021 | 409 | 0.260 |
Why?
|
| Semicircular Canals | 3 | 2011 | 198 | 0.260 |
Why?
|
| Vertigo | 3 | 2020 | 202 | 0.250 |
Why?
|
| Young Adult | 20 | 2021 | 56430 | 0.250 |
Why?
|
| Music | 1 | 2008 | 263 | 0.250 |
Why?
|
| Hearing Tests | 2 | 2004 | 122 | 0.240 |
Why?
|
| Face | 2 | 2021 | 994 | 0.240 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2023 | 88 | 0.240 |
Why?
|
| Acoustic Impedance Tests | 6 | 2009 | 109 | 0.240 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 1416 | 0.230 |
Why?
|
| Pedigree | 3 | 2022 | 4644 | 0.230 |
Why?
|
| Laryngeal Diseases | 3 | 2000 | 241 | 0.230 |
Why?
|
| Airway Obstruction | 6 | 2006 | 664 | 0.220 |
Why?
|
| Nuclear Envelope | 3 | 2007 | 172 | 0.220 |
Why?
|
| Hearing Disorders | 1 | 2003 | 124 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 10 | 2018 | 7181 | 0.220 |
Why?
|
| Neonatal Screening | 3 | 2018 | 591 | 0.220 |
Why?
|
| Ossicular Replacement | 1 | 2002 | 12 | 0.210 |
Why?
|
| Vestibule, Labyrinth | 2 | 2023 | 235 | 0.210 |
Why?
|
| Incus | 1 | 2002 | 19 | 0.210 |
Why?
|
| Auditory Threshold | 4 | 2018 | 364 | 0.210 |
Why?
|
| Gene Frequency | 5 | 2021 | 3588 | 0.210 |
Why?
|
| Reflex, Vestibulo-Ocular | 2 | 2015 | 85 | 0.210 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2021 | 4 | 0.200 |
Why?
|
| CHARGE Syndrome | 1 | 2021 | 31 | 0.200 |
Why?
|
| Pain, Postoperative | 3 | 2020 | 1643 | 0.200 |
Why?
|
| Chromosome Segregation | 3 | 2015 | 235 | 0.200 |
Why?
|
| Genome, Viral | 3 | 2020 | 667 | 0.200 |
Why?
|
| Facial Paralysis | 1 | 2005 | 338 | 0.190 |
Why?
|
| Electroretinography | 2 | 2021 | 509 | 0.190 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2019 | 209 | 0.190 |
Why?
|
| Telemedicine | 1 | 2018 | 2872 | 0.190 |
Why?
|
| Cholesteatoma | 2 | 1993 | 26 | 0.190 |
Why?
|
| Epiglottis | 1 | 2000 | 79 | 0.190 |
Why?
|
| Visual Field Tests | 2 | 2021 | 383 | 0.190 |
Why?
|
| Genetic Variation | 7 | 2021 | 6544 | 0.180 |
Why?
|
| Audiology | 1 | 2020 | 20 | 0.180 |
Why?
|
| Actinobacteria | 1 | 2020 | 56 | 0.180 |
Why?
|
| Nursing, Team | 1 | 1999 | 3 | 0.180 |
Why?
|
| Chromatids | 3 | 2004 | 63 | 0.180 |
Why?
|
| Nuclear Proteins | 7 | 2007 | 5853 | 0.180 |
Why?
|
| Physician Executives | 1 | 2020 | 128 | 0.170 |
Why?
|
| Diagnosis, Differential | 9 | 2021 | 12959 | 0.170 |
Why?
|
| Tracheostomy | 2 | 2000 | 401 | 0.170 |
Why?
|
| Transcription Factor AP-2 | 1 | 2019 | 82 | 0.170 |
Why?
|
| Ibuprofen | 1 | 2020 | 236 | 0.170 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7659 | 0.170 |
Why?
|
| Tonsillitis | 3 | 2020 | 30 | 0.160 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1999 | 79 | 0.160 |
Why?
|
| Diabetes Insipidus | 1 | 2019 | 151 | 0.160 |
Why?
|
| Genome, Human | 3 | 2021 | 4420 | 0.160 |
Why?
|
| Pediatric Nursing | 1 | 1999 | 103 | 0.160 |
Why?
|
| Clarithromycin | 1 | 2018 | 86 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2005 | 1002 | 0.160 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 1996 | 165 | 0.160 |
Why?
|
| Nuclear Localization Signals | 1 | 1998 | 80 | 0.160 |
Why?
|
| Arthrobacter | 1 | 2017 | 20 | 0.150 |
Why?
|
| Tubulin | 1 | 2021 | 695 | 0.150 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 367 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 498 | 0.150 |
Why?
|
| Mycobacteriophages | 1 | 2017 | 19 | 0.150 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 365 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9648 | 0.150 |
Why?
|
| Cleft Lip | 1 | 2022 | 478 | 0.150 |
Why?
|
| Prophages | 1 | 2017 | 38 | 0.150 |
Why?
|
| Faculty | 1 | 2020 | 386 | 0.150 |
Why?
|
| Syndrome | 5 | 2016 | 3251 | 0.140 |
Why?
|
| Hearing Loss, Central | 1 | 2016 | 16 | 0.140 |
Why?
|
| Cleft Palate | 1 | 2022 | 560 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2000 | 523 | 0.140 |
Why?
|
| Retroelements | 1 | 1998 | 164 | 0.140 |
Why?
|
| Postoperative Complications | 8 | 2010 | 15295 | 0.140 |
Why?
|
| Laryngoscopy | 5 | 2018 | 711 | 0.140 |
Why?
|
| Fungal Proteins | 3 | 2000 | 912 | 0.140 |
Why?
|
| Pharynx | 1 | 1999 | 413 | 0.140 |
Why?
|
| Reoperation | 3 | 2022 | 4201 | 0.140 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2016 | 39 | 0.140 |
Why?
|
| Mycobacterium smegmatis | 1 | 2017 | 122 | 0.140 |
Why?
|
| DNA Replication | 1 | 2003 | 1399 | 0.140 |
Why?
|
| Genes, Recessive | 3 | 2021 | 641 | 0.140 |
Why?
|
| Fingers | 1 | 2019 | 513 | 0.140 |
Why?
|
| Dizziness | 2 | 2015 | 251 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 643 | 0.130 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 1995 | 43 | 0.130 |
Why?
|
| Rubella | 1 | 2015 | 48 | 0.130 |
Why?
|
| Hyperbilirubinemia | 1 | 2015 | 77 | 0.130 |
Why?
|
| Tracheotomy | 4 | 1995 | 166 | 0.130 |
Why?
|
| Foreign Bodies | 3 | 2001 | 399 | 0.130 |
Why?
|
| Integrases | 1 | 1998 | 533 | 0.130 |
Why?
|
| Granular Cell Tumor | 1 | 1995 | 51 | 0.130 |
Why?
|
| Toxoplasmosis | 1 | 2015 | 91 | 0.130 |
Why?
|
| Tympanic Membrane | 3 | 2008 | 225 | 0.130 |
Why?
|
| Genetic Counseling | 2 | 2010 | 600 | 0.130 |
Why?
|
| Hoarseness | 1 | 1995 | 65 | 0.120 |
Why?
|
| Physical Examination | 2 | 2018 | 1237 | 0.120 |
Why?
|
| Disease Progression | 4 | 2021 | 13284 | 0.120 |
Why?
|
| Head Injuries, Closed | 1 | 2015 | 136 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2011 | 7880 | 0.120 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2000 | 570 | 0.120 |
Why?
|
| Phenotype | 9 | 2021 | 16365 | 0.120 |
Why?
|
| Neurologic Examination | 1 | 2017 | 930 | 0.120 |
Why?
|
| Patient Selection | 4 | 2012 | 4215 | 0.120 |
Why?
|
| Sequence Deletion | 2 | 2011 | 1526 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2015 | 35421 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2015 | 475 | 0.110 |
Why?
|
| Centromere | 3 | 1989 | 220 | 0.110 |
Why?
|
| Noise | 1 | 2015 | 279 | 0.110 |
Why?
|
| Chromosomes | 4 | 2006 | 596 | 0.110 |
Why?
|
| Syphilis | 1 | 2015 | 227 | 0.110 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 1206 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 1400 | 0.110 |
Why?
|
| Exoribonucleases | 1 | 1993 | 95 | 0.110 |
Why?
|
| Periodicity | 3 | 2012 | 363 | 0.110 |
Why?
|
| Larynx | 1 | 2017 | 494 | 0.110 |
Why?
|
| Fistula | 2 | 1995 | 220 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15540 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 707 | 0.100 |
Why?
|
| Herpes Simplex | 1 | 2015 | 470 | 0.100 |
Why?
|
| Cell Cycle Proteins | 3 | 2021 | 3462 | 0.100 |
Why?
|
| Aminoglycosides | 3 | 2009 | 162 | 0.100 |
Why?
|
| Visual Acuity | 1 | 2021 | 2530 | 0.100 |
Why?
|
| Electrocoagulation | 2 | 2011 | 158 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1995 | 512 | 0.100 |
Why?
|
| Otologic Surgical Procedures | 3 | 2011 | 145 | 0.100 |
Why?
|
| Pseudomonas Infections | 4 | 1998 | 613 | 0.100 |
Why?
|
| Nose Neoplasms | 2 | 2003 | 246 | 0.100 |
Why?
|
| Genes, Fungal | 1 | 1993 | 455 | 0.100 |
Why?
|
| Perilymph | 2 | 1995 | 49 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 19905 | 0.100 |
Why?
|
| Homozygote | 4 | 2011 | 1785 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 2 | 2003 | 782 | 0.100 |
Why?
|
| Cautery | 1 | 2011 | 72 | 0.100 |
Why?
|
| Leadership | 1 | 2020 | 1357 | 0.100 |
Why?
|
| Petrous Bone | 1 | 2011 | 86 | 0.090 |
Why?
|
| Craniofacial Abnormalities | 2 | 2005 | 315 | 0.090 |
Why?
|
| Adult | 19 | 2021 | 214055 | 0.090 |
Why?
|
| Genomics | 4 | 2020 | 5720 | 0.090 |
Why?
|
| Device Removal | 2 | 2022 | 656 | 0.090 |
Why?
|
| Labyrinthine Fluids | 1 | 1989 | 15 | 0.090 |
Why?
|
| Constriction, Pathologic | 2 | 2012 | 1107 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 5 | 1998 | 1219 | 0.090 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2421 | 0.090 |
Why?
|
| Retina | 1 | 2021 | 2616 | 0.090 |
Why?
|
| Counseling | 1 | 2018 | 1523 | 0.090 |
Why?
|
| Epiglottitis | 2 | 1986 | 19 | 0.090 |
Why?
|
| Laryngitis | 2 | 1986 | 27 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2019 | 2564 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 7279 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 1813 | 0.090 |
Why?
|
| Risk Assessment | 3 | 2015 | 23338 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2119 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2020 | 21746 | 0.090 |
Why?
|
| Forecasting | 1 | 2018 | 2951 | 0.080 |
Why?
|
| Saccule and Utricle | 1 | 2009 | 81 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3703 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2015 | 1660 | 0.080 |
Why?
|
| Granulation Tissue | 1 | 2008 | 93 | 0.080 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2008 | 41 | 0.080 |
Why?
|
| Respiration Disorders | 1 | 1992 | 371 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 170 | 0.080 |
Why?
|
| Cefaclor | 1 | 1987 | 8 | 0.080 |
Why?
|
| Nucleoproteins | 1 | 1988 | 115 | 0.080 |
Why?
|
| Cefotaxime | 1 | 1987 | 35 | 0.080 |
Why?
|
| Health Surveys | 1 | 2018 | 4037 | 0.080 |
Why?
|
| Cephalexin | 1 | 1987 | 37 | 0.080 |
Why?
|
| DNA, Fungal | 2 | 1989 | 280 | 0.080 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 263 | 0.080 |
Why?
|
| Digestive System | 1 | 1988 | 253 | 0.070 |
Why?
|
| Stapedius | 1 | 2007 | 24 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 415 | 0.070 |
Why?
|
| Respiratory Tract Diseases | 2 | 2003 | 722 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1040 | 0.070 |
Why?
|
| Cohort Studies | 8 | 2020 | 40561 | 0.070 |
Why?
|
| Fever | 2 | 2005 | 1616 | 0.070 |
Why?
|
| Incidence | 7 | 2021 | 20947 | 0.070 |
Why?
|
| Prospective Studies | 13 | 2016 | 53288 | 0.070 |
Why?
|
| Ear Ossicles | 1 | 2007 | 73 | 0.070 |
Why?
|
| Mastoid | 1 | 2007 | 92 | 0.070 |
Why?
|
| Epidermolysis Bullosa | 1 | 1986 | 26 | 0.070 |
Why?
|
| Halitosis | 1 | 2005 | 13 | 0.070 |
Why?
|
| Telomere-Binding Proteins | 1 | 2007 | 116 | 0.070 |
Why?
|
| Vaccination | 1 | 2018 | 3278 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 1832 | 0.070 |
Why?
|
| Base Composition | 2 | 2020 | 293 | 0.070 |
Why?
|
| United States | 6 | 2020 | 69872 | 0.070 |
Why?
|
| Fuel Oils | 1 | 1985 | 34 | 0.070 |
Why?
|
| Water Pollutants | 1 | 1985 | 26 | 0.070 |
Why?
|
| Quality of Life | 4 | 2021 | 12804 | 0.070 |
Why?
|
| Genetic Complementation Test | 3 | 1996 | 562 | 0.070 |
Why?
|
| Facial Nerve Diseases | 1 | 2005 | 50 | 0.060 |
Why?
|
| Language Development | 2 | 2020 | 187 | 0.060 |
Why?
|
| Petroleum | 1 | 1985 | 76 | 0.060 |
Why?
|
| Coal | 1 | 1985 | 119 | 0.060 |
Why?
|
| Respiratory System | 1 | 1988 | 557 | 0.060 |
Why?
|
| Eustachian Tube | 2 | 2001 | 91 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2008 | 2250 | 0.060 |
Why?
|
| Drinking | 1 | 2005 | 197 | 0.060 |
Why?
|
| Visual Fields | 1 | 2011 | 1047 | 0.060 |
Why?
|
| Intubation, Intratracheal | 4 | 2000 | 1364 | 0.060 |
Why?
|
| Checklist | 1 | 2012 | 833 | 0.060 |
Why?
|
| Facial Neoplasms | 1 | 2005 | 121 | 0.060 |
Why?
|
| Encephalocele | 1 | 1985 | 136 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2373 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2011 | 1058 | 0.060 |
Why?
|
| Ear, External | 1 | 2005 | 161 | 0.060 |
Why?
|
| Chromosome Pairing | 1 | 2003 | 47 | 0.060 |
Why?
|
| Prognosis | 6 | 2013 | 29063 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2006 | 502 | 0.060 |
Why?
|
| Facial Injuries | 1 | 2005 | 183 | 0.060 |
Why?
|
| Papilloma | 1 | 1984 | 148 | 0.060 |
Why?
|
| Replication Protein C | 1 | 2003 | 19 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3508 | 0.060 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 4320 | 0.060 |
Why?
|
| Recurrence | 4 | 2005 | 8340 | 0.060 |
Why?
|
| Phylogeny | 3 | 2020 | 2803 | 0.060 |
Why?
|
| Staphylococcus aureus | 3 | 2022 | 1451 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 13408 | 0.050 |
Why?
|
| Referral and Consultation | 3 | 2021 | 3528 | 0.050 |
Why?
|
| Radiography | 2 | 2011 | 7023 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 587 | 0.050 |
Why?
|
| Dermoid Cyst | 1 | 2003 | 93 | 0.050 |
Why?
|
| Fishes | 1 | 1985 | 569 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 547 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2020 | 2225 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17446 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12245 | 0.050 |
Why?
|
| Age Distribution | 2 | 2005 | 2902 | 0.050 |
Why?
|
| Simplexvirus | 1 | 2005 | 802 | 0.050 |
Why?
|
| Mediastinitis | 1 | 2001 | 48 | 0.050 |
Why?
|
| Water Pollutants, Chemical | 1 | 1985 | 311 | 0.050 |
Why?
|
| Mitomycin | 1 | 2002 | 259 | 0.050 |
Why?
|
| Esophagus | 2 | 2001 | 1019 | 0.050 |
Why?
|
| Esophageal Perforation | 1 | 2001 | 69 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.050 |
Why?
|
| Chronic Disease | 8 | 2006 | 9146 | 0.050 |
Why?
|
| Macaca fascicularis | 2 | 2020 | 915 | 0.050 |
Why?
|
| Middle Aged | 11 | 2020 | 213383 | 0.050 |
Why?
|
| Telomere | 1 | 2007 | 910 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1677 | 0.050 |
Why?
|
| Esophageal Stenosis | 1 | 2002 | 195 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1454 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1984 | 604 | 0.050 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2000 | 65 | 0.050 |
Why?
|
| Treatment Outcome | 11 | 2021 | 63114 | 0.050 |
Why?
|
| Malocclusion | 1 | 2001 | 130 | 0.050 |
Why?
|
| Bone Conduction | 2 | 2011 | 103 | 0.050 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 95 | 0.050 |
Why?
|
| Facial Asymmetry | 1 | 2001 | 171 | 0.050 |
Why?
|
| Chromatin | 3 | 2006 | 2934 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2020 | 5788 | 0.040 |
Why?
|
| Aged | 7 | 2020 | 163280 | 0.040 |
Why?
|
| Cricoid Cartilage | 1 | 2000 | 72 | 0.040 |
Why?
|
| Acupressure | 1 | 1999 | 16 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2003 | 959 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2021 | 275 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2000 | 139 | 0.040 |
Why?
|
| Nursing Assessment | 1 | 1999 | 107 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2020 | 718 | 0.040 |
Why?
|
| Jews | 1 | 2021 | 385 | 0.040 |
Why?
|
| Otoscopes | 1 | 1998 | 11 | 0.040 |
Why?
|
| Eating | 1 | 2005 | 1536 | 0.040 |
Why?
|
| Base Sequence | 4 | 2009 | 12797 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 1456 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2021 | 321 | 0.040 |
Why?
|
| Risk Factors | 5 | 2020 | 72290 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2003 | 18111 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2019 | 287 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 2003 | 2969 | 0.040 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 1996 | 15 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3887 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2000 | 273 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2003 | 1202 | 0.040 |
Why?
|
| Heterozygote | 3 | 2011 | 2804 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13815 | 0.040 |
Why?
|
| Lysogeny | 1 | 2017 | 67 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 545 | 0.040 |
Why?
|
| Infant, Premature | 1 | 1987 | 2044 | 0.040 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 441 | 0.040 |
Why?
|
| Histones | 3 | 2003 | 2599 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2019 | 658 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 2839 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 1998 | 315 | 0.040 |
Why?
|
| Familial Mediterranean Fever | 1 | 2016 | 61 | 0.040 |
Why?
|
| NAD | 1 | 2000 | 593 | 0.030 |
Why?
|
| Transgenes | 1 | 2020 | 1009 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 824 | 0.030 |
Why?
|
| Turkey | 1 | 2016 | 237 | 0.030 |
Why?
|
| Cicatrix | 1 | 2002 | 764 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2001 | 1420 | 0.030 |
Why?
|
| Nausea | 1 | 1999 | 673 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2021 | 907 | 0.030 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2016 | 136 | 0.030 |
Why?
|
| Otitis Externa | 1 | 1995 | 19 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2021 | 859 | 0.030 |
Why?
|
| Vomiting | 1 | 1999 | 636 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10262 | 0.030 |
Why?
|
| Papain | 1 | 1975 | 64 | 0.030 |
Why?
|
| Ear Cartilage | 1 | 1995 | 62 | 0.030 |
Why?
|
| Ligases | 1 | 2017 | 333 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1790 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2000 | 728 | 0.030 |
Why?
|
| Bacteria | 1 | 1986 | 2114 | 0.030 |
Why?
|
| Tracheal Stenosis | 2 | 2002 | 226 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2925 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 1995 | 193 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 706 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1999 | 464 | 0.030 |
Why?
|
| Patient Care Team | 2 | 2012 | 2531 | 0.030 |
Why?
|
| Codeine | 1 | 2014 | 49 | 0.030 |
Why?
|
| Likelihood Functions | 2 | 2009 | 1005 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 1723 | 0.030 |
Why?
|
| Porins | 1 | 1994 | 81 | 0.030 |
Why?
|
| S Phase | 2 | 2006 | 423 | 0.030 |
Why?
|
| Quinolinic Acid | 1 | 1994 | 67 | 0.030 |
Why?
|
| Transferrin | 1 | 1995 | 295 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1301 | 0.030 |
Why?
|
| Apnea | 1 | 1995 | 195 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2003 | 1775 | 0.030 |
Why?
|
| Trachea | 1 | 2000 | 1076 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 39050 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1941 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1997 | 767 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 1998 | 1438 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1842 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1993 | 218 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 1813 | 0.030 |
Why?
|
| Tongue | 1 | 1995 | 406 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1996 | 1266 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3658 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2017 | 760 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1783 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1989 | 212 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1989 | 570 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2013 | 569 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14722 | 0.020 |
Why?
|
| DNA Primers | 1 | 1996 | 2892 | 0.020 |
Why?
|
| Time Factors | 5 | 2005 | 40075 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4803 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2011 | 256 | 0.020 |
Why?
|
| Medical History Taking | 1 | 1995 | 783 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 972 | 0.020 |
Why?
|
| Administration, Topical | 3 | 2002 | 690 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 2011 | 219 | 0.020 |
Why?
|
| Visual Cortex | 1 | 1998 | 1149 | 0.020 |
Why?
|
| Deglutition | 1 | 1992 | 197 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1997 | 1486 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 2924 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2020 | 3420 | 0.020 |
Why?
|
| Vocal Cords | 1 | 1995 | 528 | 0.020 |
Why?
|
| Electromyography | 2 | 2009 | 1379 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 655 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 204 | 0.020 |
Why?
|
| Zebrafish | 1 | 2021 | 2994 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2017 | 1900 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1976 | 2455 | 0.020 |
Why?
|
| Monocytes | 2 | 1976 | 2596 | 0.020 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 1641 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3597 | 0.020 |
Why?
|
| HIV Infections | 1 | 2015 | 16718 | 0.020 |
Why?
|
| Endoscopy | 1 | 1999 | 1785 | 0.020 |
Why?
|
| Temperature | 2 | 2006 | 2206 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1988 | 17 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1984 | 4034 | 0.020 |
Why?
|
| Ion Transport | 1 | 2009 | 320 | 0.020 |
Why?
|
| Cefixime | 1 | 1987 | 12 | 0.020 |
Why?
|
| Cysts | 1 | 1993 | 678 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3527 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2009 | 250 | 0.020 |
Why?
|
| Tympanoplasty | 1 | 1987 | 71 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3772 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1252 | 0.020 |
Why?
|
| Neurons | 2 | 1998 | 9338 | 0.020 |
Why?
|
| Visual Perception | 1 | 2015 | 1420 | 0.020 |
Why?
|
| Cadaver | 1 | 2011 | 1337 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 2 | 1992 | 850 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1375 | 0.020 |
Why?
|
| Parents | 1 | 2020 | 3407 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 3743 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 4986 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2006 | 2440 | 0.020 |
Why?
|
| Algorithms | 3 | 2017 | 13881 | 0.020 |
Why?
|
| Chlorides | 1 | 2009 | 667 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 15519 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9583 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2006 | 136 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1992 | 706 | 0.020 |
Why?
|
| Corynebacterium | 1 | 1986 | 47 | 0.020 |
Why?
|
| Animals | 8 | 2021 | 168757 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18370 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2011 | 694 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1986 | 95 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2010 | 451 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2009 | 525 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 1986 | 171 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 1572 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 2126 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2009 | 957 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18029 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
| Bronchoscopy | 3 | 2000 | 862 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1986 | 647 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1995 | 1877 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 1985 | 378 | 0.020 |
Why?
|
| Sphenoid Bone | 1 | 1985 | 172 | 0.020 |
Why?
|
| Otoscopy | 1 | 2004 | 36 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 1976 | 4560 | 0.020 |
Why?
|
| Ear Diseases | 1 | 1986 | 170 | 0.020 |
Why?
|
| Mastoiditis | 1 | 1984 | 34 | 0.020 |
Why?
|
| Oocytes | 1 | 2009 | 1187 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2010 | 1056 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 464 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4982 | 0.010 |
Why?
|
| Genome, Fungal | 1 | 2004 | 204 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 1985 | 373 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1985 | 490 | 0.010 |
Why?
|
| Protein Binding | 2 | 2007 | 9386 | 0.010 |
Why?
|
| China | 1 | 2009 | 2248 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1970 | 0.010 |
Why?
|
| G1 Phase | 1 | 2004 | 415 | 0.010 |
Why?
|
| Speech Disorders | 1 | 2004 | 189 | 0.010 |
Why?
|
| Language Development Disorders | 1 | 2004 | 196 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 595 | 0.010 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 25043 | 0.010 |
Why?
|
| Choanal Atresia | 1 | 2002 | 39 | 0.010 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1984 | 234 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11366 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6459 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 905 | 0.010 |
Why?
|
| Canada | 1 | 2007 | 2065 | 0.010 |
Why?
|
| Pediatrics | 1 | 2016 | 3475 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2006 | 736 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2011 | 3420 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1985 | 1063 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1982 | 180 | 0.010 |
Why?
|
| Sudden Infant Death | 1 | 2003 | 291 | 0.010 |
Why?
|
| Mass Screening | 1 | 2016 | 5255 | 0.010 |
Why?
|
| Nasal Polyps | 1 | 1985 | 360 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1995 | 3507 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2001 | 152 | 0.010 |
Why?
|
| Sirtuin 2 | 1 | 2000 | 97 | 0.010 |
Why?
|
| Laryngostenosis | 1 | 2002 | 161 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1081 | 0.010 |
Why?
|
| Psychotherapy | 1 | 1969 | 1643 | 0.010 |
Why?
|
| Oncogenes | 1 | 1985 | 1265 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15076 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 696 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2001 | 390 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 2019 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 2000 | 290 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1208 | 0.010 |
Why?
|
| Shock, Septic | 1 | 1986 | 775 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 2657 | 0.010 |
Why?
|
| Polymyxin B | 1 | 1998 | 46 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2256 | 0.010 |
Why?
|
| Neomycin | 1 | 1998 | 88 | 0.010 |
Why?
|
| Sirtuin 1 | 1 | 2000 | 246 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1986 | 6489 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2000 | 222 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1364 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2003 | 602 | 0.010 |
Why?
|
| Drainage | 1 | 1984 | 1142 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 440 | 0.010 |
Why?
|
| Gestational Age | 1 | 1987 | 3493 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3749 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 1998 | 8037 | 0.010 |
Why?
|
| Sirtuins | 1 | 2000 | 323 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1986 | 1401 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1986 | 1199 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 3128 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1976 | 191 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12026 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 1275 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1987 | 2684 | 0.010 |
Why?
|
| Sinusitis | 1 | 1985 | 923 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7785 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3846 | 0.010 |
Why?
|
| Immune Adherence Reaction | 1 | 1975 | 32 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1975 | 75 | 0.010 |
Why?
|
| Cochlear Aqueduct | 1 | 1995 | 7 | 0.010 |
Why?
|
| Oval Window, Ear | 1 | 1995 | 21 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2000 | 2297 | 0.010 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1975 | 65 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1975 | 363 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 5952 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1975 | 349 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 1586 | 0.010 |
Why?
|
| Immune Sera | 1 | 1975 | 641 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 12072 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1547 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4740 | 0.010 |
Why?
|
| alpha Karyopherins | 1 | 1994 | 41 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 1940 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1985 | 10943 | 0.010 |
Why?
|
| Audiometry, Evoked Response | 1 | 1994 | 44 | 0.010 |
Why?
|
| Mice | 2 | 2020 | 81183 | 0.010 |
Why?
|
| Round Window, Ear | 1 | 1994 | 47 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1994 | 242 | 0.010 |
Why?
|
| Chinchilla | 1 | 1994 | 75 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1994 | 829 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1985 | 2541 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1998 | 1959 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1994 | 361 | 0.010 |
Why?
|
| Mouth Breathing | 1 | 1992 | 19 | 0.010 |
Why?
|
| Prevalence | 1 | 1989 | 15226 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12261 | 0.010 |
Why?
|
| Maxillofacial Development | 1 | 1992 | 88 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1975 | 795 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2003 | 13033 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1984 | 8642 | 0.010 |
Why?
|
| Sepsis | 1 | 1986 | 2593 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 13989 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 57776 | 0.010 |
Why?
|
| Wound Healing | 1 | 2002 | 2785 | 0.010 |
Why?
|
| Immunization | 1 | 1975 | 1256 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1826 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1975 | 1537 | 0.010 |
Why?
|
| Stents | 1 | 2002 | 3280 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1976 | 3144 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1992 | 414 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 7301 | 0.010 |
Why?
|
| Enuresis | 1 | 1969 | 47 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 10388 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1969 | 6600 | 0.010 |
Why?
|
| Rabbits | 1 | 1975 | 4894 | 0.010 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1989 | 121 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1995 | 5179 | 0.000 |
Why?
|
| Dimethylhydrazines | 1 | 1985 | 12 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1984 | 9239 | 0.000 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1987 | 154 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 2004 | 5319 | 0.000 |
Why?
|
| Poly A | 1 | 1985 | 185 | 0.000 |
Why?
|
| Nucleosomes | 1 | 1989 | 494 | 0.000 |
Why?
|
| Amoxicillin | 1 | 1985 | 170 | 0.000 |
Why?
|
| Injections | 1 | 1985 | 840 | 0.000 |
Why?
|
| RNA, Neoplasm | 1 | 1985 | 769 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1989 | 2967 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1985 | 1758 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1985 | 3913 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1985 | 4933 | 0.000 |
Why?
|
| Receptors, Concanavalin A | 1 | 1976 | 11 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1985 | 6386 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1976 | 683 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1982 | 2924 | 0.000 |
Why?
|
| Anxiety | 1 | 1969 | 4297 | 0.000 |
Why?
|
| Risk | 1 | 1985 | 9687 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1976 | 1539 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1982 | 3474 | 0.000 |
Why?
|
| Depression | 1 | 1969 | 7766 | 0.000 |
Why?
|
| Kinetics | 1 | 1976 | 6473 | 0.000 |
Why?
|
| Aging | 1 | 1987 | 8664 | 0.000 |
Why?
|
| Binding Sites | 1 | 1976 | 6114 | 0.000 |
Why?
|